PSEN1 Expression Identifies a Developmentally Distinct Favorable-Prognosis State in SHH α Medulloblastoma
- 1Federal University of Rio Grande do Sul
Abstract
Background: Although PSEN1 is best known for its role in Alzheimer's disease, it also regulates neural development and cerebellar morphogenesis. Medulloblastoma (MB) is the most common malignant pediatric brain tumor and arises from disrupted cerebellar developmental programs. The clinical significance of PSEN1 in MB remains unknown. We investigated the prognostic value and transcriptional correlates of PSEN1 expression across molecular subgroups and subtypes of MB. Methods: Public bulk and single-cell transcriptomic datasets were used to examine PSEN1 expression, associations with overall survival (OS), and transcriptional correlates in MB. The SHH -associated transcriptional pattern was evaluated in an independent cohort, and PSEN1 expression was further examined in the developing human cerebellum and across pediatric brain tumor types. Genes strongly correlated with PSEN1 in SHH MB were subjected to Gene Ontology (GO) enrichment analysis. Results: High PSEN1 expression was consistently associated with significantly longer OS exclusively in SHH MB. The PSEN1-associated transcriptional pattern was reproduced in an independent SHH cohort. PSEN1 was expressed across developing cerebellar cell populations and pediatric brain tumor types, with MB showing intermediate expression among the tumor entities examined. In SHH MB, PSEN1 was associated with a coordinated transcriptional program enriched for RNA homeostasis, intracellular membrane trafficking, protein quality control, lipid and calcium signaling, and developmental pathways. Conclusions: High PSEN1 expression identifies a favorable-prognosis subset of SHH MB and is associated with a distinct transcriptional program related to endomembrane organization and cellular homeostasis rather than canonical SHH signaling. These findings suggest that PSEN1 may mark a developmentally distinct tumor state and generate new hypotheses regarding subtype-specific developmental programs in MB.
Related
- Endothelial p16 expression identifies a subgroup of clear cell renal cell carcinoma with favorable prognosis
- Larger Non-metastatic No. 8 Lymph Node Size Is Associated With Favorable Prognosis After Pancreaticoduodenectomy for Pancreatic Cancer.
- Single‑cell and bulk RNA sequencing identifies T cell marker genes to predict the prognosis of ovarian cancer
- Multi‐Omics Integration Identifies a CDH3‐Associated Malignant Epithelial State and Immunosuppressive Niche to Predict Prognosis in Thymic Epithelial Tumors
- Integrated transcriptomics identifies key genes and pathways driving CKD to ESRD progression: implications for diagnosis and prognosis
BibTeX
@misc{vanini2026psen1,
title = {{PSEN1 Expression Identifies a Developmentally Distinct Favorable-Prognosis State in SHH α Medulloblastoma}},
author = {J. Vanini and A. Thomaz and M. M. Lupatini and A. T. Brunetto and C. B. de Farias and M. Jaeger and R. Roesler},
howpublished = {bioRxiv},
year = {2026},
month = aug,
doi = {10.64898/2026.08.21.746295},
url = {https://www.biorxiv.org/content/10.64898/2026.08.21.746295v3},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - PSEN1 Expression Identifies a Developmentally Distinct Favorable-Prognosis State in SHH α Medulloblastoma
AU - J. Vanini
AU - A. Thomaz
AU - M. M. Lupatini
AU - A. T. Brunetto
AU - C. B. de Farias
AU - M. Jaeger
AU - R. Roesler
PY - 2026
DA - 2026/08/21
PB - bioRxiv
DO - 10.64898/2026.08.21.746295
UR - https://www.biorxiv.org/content/10.64898/2026.08.21.746295v3
AB - Background: Although PSEN1 is best known for its role in Alzheimer's disease, it also regulates neural development and cerebellar morphogenesis. Medulloblastoma (MB) is the most common malignant pediatric brain tumor and arises from disrupted cerebellar developmental programs. The clinical significance of PSEN1 in MB remains unknown. We investigated the prognostic value and transcriptional correlates of PSEN1 expression across molecular subgroups and subtypes of MB. Methods: Public bulk and single-cell transcriptomic datasets were used to examine PSEN1 expression, associations with overall survival (OS), and transcriptional correlates in MB. The SHH -associated transcriptional pattern was evaluated in an independent cohort, and PSEN1 expression was further examined in the developing human cerebellum and across pediatric brain tumor types. Genes strongly correlated with PSEN1 in SHH MB were subjected to Gene Ontology (GO) enrichment analysis. Results: High PSEN1 expression was consistently associated with significantly longer OS exclusively in SHH MB. The PSEN1-associated transcriptional pattern was reproduced in an independent SHH cohort. PSEN1 was expressed across developing cerebellar cell populations and pediatric brain tumor types, with MB showing intermediate expression among the tumor entities examined. In SHH MB, PSEN1 was associated with a coordinated transcriptional program enriched for RNA homeostasis, intracellular membrane trafficking, protein quality control, lipid and calcium signaling, and developmental pathways. Conclusions: High PSEN1 expression identifies a favorable-prognosis subset of SHH MB and is associated with a distinct transcriptional program related to endomembrane organization and cellular homeostasis rather than canonical SHH signaling. These findings suggest that PSEN1 may mark a developmentally distinct tumor state and generate new hypotheses regarding subtype-specific developmental programs in MB.
ER -